Re-evaluation of the molecular pharmacology of mitomycin C

被引:45
作者
Cummings, J
Spanswick, VJ
Smyth, JF
机构
[1] Imperial Cancer Research Fund, Medical Oncology Unit, Western General Hospital, Edinburgh
关键词
D O I
10.1016/0959-8049(95)00364-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1928 / 1933
页数:6
相关论文
共 60 条
[1]  
BEALL HD, 1994, CANCER RES, V54, P3196
[2]   DISTORTION AFTER MONOFUNCTIONAL ALKYLATION BY MITOMYCIN-C OF A DODECAMER CONTAINING ITS MAJOR BINDING-SITE [J].
BERTHELIER, V ;
LAIGLE, A ;
JOLLES, B ;
CHINSKY, L .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1995, 12 (04) :899-910
[3]  
BIZANEK R, 1993, CANCER RES, V53, P5127
[4]   ISOLATION AND STRUCTURE OF AN INTRASTRAND CROSS-LINK ADDUCT OF MITOMYCIN-C AND DNA [J].
BIZANEK, R ;
MCGUINNESS, BF ;
NAKANISHI, K ;
TOMASZ, M .
BIOCHEMISTRY, 1992, 31 (12) :3084-3091
[5]  
BUTLER J, 1987, British Journal of Cancer, V55, P53
[6]  
CARTER SK, 1979, MITOMYCIN C CURRENT
[7]   CONVERSION OF MITOMYCIN-C TO 2,7-DIAMINOMITOSENE AND 10-DECARBAMOYL 2,7-DIAMINOMITOSENE IN TUMOR-TISSUE IN-VIVO [J].
CHIRREY, L ;
CUMMINGS, J ;
HALBERT, GW ;
SMYTH, JF .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (04) :318-322
[8]   ENCAPSULATION OF MITOMYCIN-C IN ALBUMIN MICROSPHERES MARKEDLY ALTERS PHARMACOKINETICS, DRUG QUINONE REDUCTION IN TUMOR-TISSUE AND ANTITUMOR-ACTIVITY - IMPLICATIONS FOR THE DRUGS IN-VIVO MECHANISM OF ACTION [J].
CUMMINGS, J ;
ALLAN, L ;
SMYTH, JF .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (08) :1345-1356
[9]   THE ENZYMOLOGY OF DOXORUBICIN QUINONE REDUCTION IN TUMOR-TISSUE [J].
CUMMINGS, J ;
ALLAN, L ;
WILLMOTT, N ;
RILEY, R ;
WORKMAN, P ;
SMYTH, JF .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2175-2183
[10]   DETERMINATION OF MITOMYCIN-C, 2,7-DIAMINOMITOSENE, 1,2-CIS-1-HYDROXY-2 AND 1,2-TRANS-1-HYDROXY-2,7-DIAMINOMITOSENE IN TUMOR-TISSUE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CUMMINGS, J ;
CHIRREY, L ;
WILLMOTT, N ;
HALBERT, GW ;
SMYTH, JF .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1993, 612 (01) :105-113